Assert-IQ vs ACUSON Sequoia Select Diagnostic Ultrasound System
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Assert-IQ is an insertable cardiac monitor designed for long-term, continuous detection and management of heart rhythm disorders. In contrast, the ACUSON Sequoia Select is an AI-powered diagnostic ultrasound system focused on high-quality imaging for various clinical applications, including cardiology. While both utilize AI in cardiology, they address different aspects of patient care: one for physiological monitoring and the other for anatomical and functional imaging.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Assert-IQ is an Insertable Cardiac Monitor system designed for long-term, continuous monitoring and advanced arrhythmia detection to aid in diagnosing and managing patients with suspected heart rhythm disorders. ACUSON Sequoia Select is an advanced, AI-powered diagnostic ultrasound system featuring BioAcousticu2122 imaging technology for exceptional image quality and enhanced diagnostic confidence across diverse patient populations and clinical applications, including cardiology.
Assert-IQ utilizes advanced arrhythmia detection algorithms for continuous cardiac monitoring, aiming to reduce false positives and enhance accuracy in detecting conditions like AF and Pause episodes. ACUSON Sequoia Select is an AI-powered ultrasound platform that integrates smart automation, including UltraArt for automatic image parameter settings, to optimize workflow and deliver personalized ultrasound imaging.
Assert-IQ provides long-term continuous cardiac monitoring for up to 6 years, aiding in the detection of arrhythmias over an extended period. In contrast, ACUSON Sequoia Select is a diagnostic ultrasound system designed for real-time imaging, providing immediate diagnostic assessment with features like InFocus Imaging for fully focused images.
Assert-IQ is indicated for monitoring and diagnostic evaluation of patients with unexplained symptoms that may be cardiac-related, such as dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as those at risk for or previously diagnosed with atrial fibrillation. ACUSON Sequoia Select is suited for a broad range of diagnostic imaging needs in cardiology, leveraging BioAcousticu2122 imaging and deep penetration capabilities for enhanced diagnostic confidence across diverse patient populations.
Assert-IQ features advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, remote monitoring capabilities, and a patient activator for symptom logging. ACUSON Sequoia Select boasts BioAcousticu2122 Imaging Technology, InFocus Imaging, InTune Transducer Technology, and the DAX Transducer for deep abdominal penetration up to 40cm.